Concise review: cell therapy for critical limb ischemia: an integrated review of preclinical and clinical studies

M Qadura, DC Terenzi, S Verma, M Al-Omran… - Stem …, 2018 - academic.oup.com
Critical limb ischemia (CLI), the most severe form of peripheral artery disease, is
characterized by pain at rest and non-healing ulcers in the lower extremities. For patients …

Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease

S Sen, SP McDonald, PTH Coates… - Clinical science, 2011 - portlandpress.com
Bone-marrow-derived EPCs (endothelial progenitor cells) play an integral role in the
regulation and protection of the endothelium, as well as new vessel formation. Peripheral …

Working hypothesis to redefine endothelial progenitor cells

DN Prater, J Case, DA Ingram, MC Yoder - Leukemia, 2007 - nature.com
Since 1997, postnatal vasculogenesis has been purported to be an important mechanism for
neoangiogenesis via bone marrow (BM)-derived circulating endothelial progenitor cells …

Stem cell and progenitor cell therapy in peripheral artery disease

H Lawall, P Bramlage, B Amann - Thrombosis and haemostasis, 2010 - thieme-connect.com
Atherosclerotic peripheral artery disease (PAD) is a common manifestation of
atherosclerosis. The occlusion of large limb arteries leads to ischaemia with claudication …

Ischemic vascular damage can be repaired by healthy, but not diabetic, endothelial progenitor cells

S Caballero, N Sengupta, A Afzal, KH Chang… - Diabetes, 2007 - Am Diabetes Assoc
Endothelial precursor cells (EPCs) play a key role in vascular repair and maintenance, and
their function is impeded in diabetes. We previously demonstrated that EPCs isolated from …

Endothelial progenitor cell therapy for chronic wound tissue regeneration

K Kaushik, A Das - Cytotherapy, 2019 - Elsevier
Despite advancements in wound care, healing of chronic diabetic wounds remains a great
challenge for the clinical fraternity because of the intricacies of the healing process. Due to …

Endothelial progenitor cell-based neovascularization: implications for therapy

G Krenning, MJA van Luyn, MC Harmsen - Trends in molecular medicine, 2009 - cell.com
Ischemic cardiovascular events are a major cause of death globally. Endothelial progenitor
cell (EPC)-based approaches can result in improvement of vascular perfusion and might …

A comparison of the tube forming potentials of early and late endothelial progenitor cells

N Mukai, T Akahori, M Komaki, Q Li… - Experimental cell …, 2008 - Elsevier
The identification of circulating endothelial progenitor cells (EPCs) has revolutionized
approaches to cell-based therapy for injured and ischemic tissues. However, the …

Revascularization of ischemic limbs after transplantation of human bone marrow cells with high aldehyde dehydrogenase activity

BJ Capoccia, DL Robson, KD Levac… - Blood, The Journal …, 2009 - ashpublications.org
The development of cell therapies to treat peripheral vascular disease has proven difficult
because of the contribution of multiple cell types that coordinate revascularization. We …

Ex vivo priming of endothelial progenitor cells with SDF-1 before transplantation could increase their proangiogenic potential

F Zemani, JS Silvestre, F Fauvel-Lafeve… - … , and vascular biology, 2008 - Am Heart Assoc
Objectives—As SDF-1 and its cognate receptor CXCR4 play a key role in the survival and
mobilization of immature cells, we examined whether preconditioning of endothelial …